<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Peng YH</submitter><funding>National Natural Science Foundation of China</funding><pagination>1388-96</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4944864</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(7)</volume><pubmed_abstract>Esophageal squamous cell carcinoma (ESCC) can be treated effectively if diagnosed at an early stage. We evaluated whether measurement of Dickkopf-1 (DKK-1) in combination of DKK-1 autoantibodies in serum may benefit early diagnosis of ESCC. Serum DKK-1 and DKK-1 autoantibodies were measured by enzyme-linked immunosorbent assay in a training cohort (185 ESCC samples vs. 97 normal controls) and validated in a validation cohort (104 ESCC samples vs. 53 normal controls). Receiver operating characteristic (ROC) was applied to calculate diagnostic accuracy. Testing of DKK-1 and DKK-1 autoantibodies together could differentiate ESCC from normal controls (area under the ROC curve [AUC] 0.769, 95% confidence interval (CI), 0.715-0.823, 50.3% sensitivity, and 90.7% specificity in the training cohort</pubmed_abstract><journal>Cancer medicine</journal><pubmed_title>Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.</pubmed_title><pmcid>PMC4944864</pmcid><funding_grant_id>81172264</funding_grant_id><funding_grant_id>81472613</funding_grant_id><pubmed_authors>Tan HZ</pubmed_authors><pubmed_authors>Li EM</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Hong CQ</pubmed_authors><pubmed_authors>Peng YH</pubmed_authors><pubmed_authors>Huang LS</pubmed_authors><pubmed_authors>Xu YW</pubmed_authors><pubmed_authors>Li SS</pubmed_authors><pubmed_authors>Xu LY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.</name><description>Esophageal squamous cell carcinoma (ESCC) can be treated effectively if diagnosed at an early stage. We evaluated whether measurement of Dickkopf-1 (DKK-1) in combination of DKK-1 autoantibodies in serum may benefit early diagnosis of ESCC. Serum DKK-1 and DKK-1 autoantibodies were measured by enzyme-linked immunosorbent assay in a training cohort (185 ESCC samples vs. 97 normal controls) and validated in a validation cohort (104 ESCC samples vs. 53 normal controls). Receiver operating characteristic (ROC) was applied to calculate diagnostic accuracy. Testing of DKK-1 and DKK-1 autoantibodies together could differentiate ESCC from normal controls (area under the ROC curve [AUC] 0.769, 95% confidence interval (CI), 0.715-0.823, 50.3% sensitivity, and 90.7% specificity in the training cohort</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jul</publication><modification>2025-04-18T18:10:07.298Z</modification><creation>2019-03-27T02:18:21Z</creation></dates><accession>S-EPMC4944864</accession><cross_references><pubmed>26988995</pubmed><doi>10.1002/cam4.702</doi></cross_references></HashMap>